Hesperetin-Loaded Solid Lipid Nanoparticles and Nanostructure Lipid Carriers for Food Fortification: Preparation, Characterization, and Modeling

Food and Bioprocess Technology

Volumn 6, Issue 6, 2013, Pages 1464-1475

  Fathi, Milad ^a   Varshosaz, Jaleh ^b   Mohebbi, Mohebbat ^a   Shahidi, Fakhri ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hesperetin; Nanostructure lipid carriers; Solid lipid nanocarriers

Indexed keywords

ENCAPSULATION EFFICIENCY; HESPERETIN; NANO-CARRIERS; NANOSTRUCTURE LIPID CARRIERS; SIGNIFICANT DIFFERENCES; SIMULATED GASTROINTESTINAL CONDITIONS; SOLID LIPID NANOPARTICLE (SLN); ZETA POTENTIAL ANALYSIS;

CRYSTALLINE MATERIALS; DIFFERENTIAL SCANNING CALORIMETRY; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOPARTICLES; X RAY DIFFRACTION; ZETA POTENTIAL;

FLAVONOIDS;

EID: 84876907254     PISSN: 19355130     EISSN: 19355149     Source Type: Journal    
DOI: 10.1007/s11947-012-0845-2     Document Type: Article

References (33)

1. Acosta, E. (2006). Testing the effectiveness of nutrient delivery systems. In N. Garti (Ed.), Delivery and controlled release of bioactives in foods and nutraceuticals. Boca Raton: CRC.
2. Borradaile, N., Carroll, K., & Kurowska, E. (1999). Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids, 34(6), 591-598.
3. Chakraborty, M., Dasgupta, S., Soundrapandian, C., Chakraborty, J., Ghosh, S., Mitra, M. K., & Basu, D. (2011). Methotrexate intercalated ZnAl-layered double hydroxide. Journal of Solid State Chemistry, 184(9), 2439-2445.
4. Crowe, L. M., Womersley, C., Crowe, J. H., Reid, D., Appel, L., & Rudolph, A. (1986). Prevention of fusion and leakage in freeze-dried liposomes by carbohydrates. Biochimica et Biophysica Acta (BBA) - Biomembranes, 861, 131-140.
5. Erlund, I. (2004). Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutrition Research, 24(10), 851-874.
6. Fathi, M., Mozafari, M. R., & Mohebbi, M. (2012). Nanoencapsulation of food ingredients using lipid based delivery systems. Trends in Food Science and Technology, 23, 13-27.
7. Ficarra, R., Tommasini, S., Raneri, D., Calabrò, M. L., Di Bella, M. R., Rustichelli, C., Gamberini, M. C., & Ficarra, P. (2002). Study of flavonoids/β-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation. Journal of Pharmaceutical and Biomedical Analysis, 29(6), 1005-1014.
8. Freitas, C., & Muller, R. H. (1998). Spray-drying of solid lipid nanoparticles (SLNTM). European Journal of Pharmaceutics and Biopharmaceutics, 46(2), 145-151.
9. Frost, M. B., Dijksterhuis, G., & Martens, M. (2001). Sensory perception of fat in milk. Food Quality and Preference, 12(5-7), 327-336.
10. Gabbott, P. (2008). A practical introduction to differential scanning calorimetry. In P. Gabbott (Ed.), Principles and applications of thermal analysis (pp. 1-50). Oxford: Blackwell.
11. Hentschel, A., Gramdorf, S., Müller, R. H., & Kurz, T. (2008). β-Carotene-loaded nanostructured lipid carriers. Journal of Food Science, 73(2), N1-N6.
12. Higuchi, T. (1963). Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences, 52, 1145-1149.
13. Horcajada, M. N., & Coxam, V. (2004). Hesperidin, a citrus flavanone, improves bone acquisition and prevents skeletal impairment in rats in nutritional aspects of osteoporosis. New York: Elsevier.
14. Li, F., Jin, L., Han, J., Wei, M., & Li, C. (2009). Synthesis and controlled release properties of prednisone intercalated Mg-Al layered double hydroxide composite. Industrial and Engineering Chemistry Research, 48(12), 5590-5597.
15. Luykx, D. M. A. M., Peters, R. J. B., van Ruth, S. M., & Bouwmeester, H. (2008). A review of analytical methods for the identification and characterization of nano delivery systems in food. Journal of Agricultural and Food Chemistry, 56(18), 8231-8247.
16. Miyagi, Y., Om, A. S., Chee, K. M., & Bennink, M. R. (2000). Inhibition of azoxymethane-induced colon cancer by orange juice. Nutrition and Cancer, 36(2), 224-229.
17. Müller, R. H., Radtke, M., & Wissing, S. A. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews, 54, S131-S155.
18. Nash, R. A., & Haeger, B. E. (1966). Zeta potential in the development of pharmaceutical suspensions. Journal of Pharmaceutical Sciences, 55(8), 829-837.
19. Pardeike, J., Hommoss, A., & Muller, R. H. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. International Journal of Pharmaceutics, 366(1-2), 170-184.
20. Sansone, F., Rossi, A., Del Gaudio, P., De Simone, F., Aquino, R., & Lauro, M. (2009). Hesperidin gastroresistant microparticles by spray-drying: preparation, characterization, and dissolution profiles. AAPS PharmSciTech, 10(2), 391-401.
21. Schwarz, C., & Mehnert, W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). International Journal of Pharmaceutics, 157(2), 171-179.
22. Sezer, A. D., Kazak, H., Oner, E. T., & Akbuga, J. I. (2011). Levan-based nanocarrier system for peptide and protein drug delivery: optimization and influence of experimental parameters on the nanoparticle characteristics. Carbohydrate Polymers, 84(1), 358-363.
23. So, F. V., Guthrie, N., Chambers, A. F., Moussa, M., & Carroll, K. K. (1996). Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutrition and Cancer, 26(2), 167-181.
24. Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., & Ogawa, H. (1997). Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis, 18(5), 957-965.
25. Tomás-Barberán, F. A., & Clifford, M. N. (2000). Flavanones, chalcones and dihydrochalcones-nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture, 80(7), 1073-1080.
26. Tommasini, S., Calabrò, M. L., Stancanelli, R., Donato, P., Costa, C., Catania, S., Villari, V., Ficarra, P., & Ficarra, R. (2005). The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-[beta]-cyclodextrin. Journal of Pharmaceutical and Biomedical Analysis, 39(3-4), 572-580.
27. Varshosaz, J., Ghaffari, S., Khoshayand, M. R., Atyabi, F., Azarmi, S., & Kobarfard, F. (2010). Development and optimization of solid lipid nanoparticles of amikacin by central composite design. Journal of Liposome Research, 20(2), 97-104.
28. Varshosaz, J., Minayian, M., & Moazen, E. (2010). Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. Journal of Liposome Research, 20(2), 115-123.
29. Venkateswarlu, V., & Manjunath, K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of Controlled Release, 95(3), 627-638.
30. Weiss, J., Decker, E. A., McClements, D. J., Kristbergsson, K., Helgason, T., & Awad, T. (2008). Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophysics, 3, 146-154.
31. Westesen, K., Siekmann, B., & Koch, M. H. J. (1993). Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. International Journal of Pharmaceutical, 93, 189-199.
32. Yang, S., & Washington, C. (2006). Drug release from microparticulate systems. In S. Benita (Ed.), Microencapsulation: methods and industrial applications. New York: Taylor & Francis Grou0p.
33. zur Muhlen, A., Schwarz, C., & Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. European Journal of Pharmaceutics and Biopharmaceutics, 45(2), 149-155.